Created in 2014 (United Kingdom), EFURLAZ own 1722 sister brands and 17479 competing brands. EFURLAZ is owned by GSK PLC, listed on the stock exchange of London The ISIN, the company's International Securities Identification Number, is GB00BN7SWP63. EFURLAZ belongs to the Drug Manufacturers business sector.

EFURLAZ is a brand of GSK PLC (GSK/L) News

News from the brand EFURLAZ

All news Marketscreener Logo
GSK PLC (EFURLAZ)

loader
Stock exchange: More information on GSK PLC (EFURLAZ) Marketscreener Logo